Tag: AF

Append Medical raises US$4.35 million in initial closing of extended series...

Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator. Investors include...

ADVERTORIAL: Pulsed field ablation: A new frontier in the treatment of...

This article was sponsored by Biosense Webster According to data published by Patrick M McCarthy (Feinberg School of Medicine, Chicago, USA) and colleagues in the...

HRS 2023: Late-breaking clinical trial results support PFA as treatment option...

New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
Biosense Webster

Biosense Webster QDot Micro catheter found to improve ablation efficiency for...

  Biosense Webster—a stem of Johnson & Johnson MedTech—announced that data from the Q-FFICIENCY study was published in JACC: Clinical Electrophysiology. The study evaluated the...
ICD

Study results demonstrate high detection accuracy for atrial fibrillation using single-lead...

Results from the MATRIX study show that the high detection accuracy of DX single-lead implantable cardioverter defibrillator (ICD) systems for atrial fibrillation (AF) episodes...
medtronic

Medtronic mapping and ablation system shows “safety and performance” in treating...

Medtronic have announced the 12-month findings that supported the Affera Mapping and Ablation system CE Mark, demonstrating that the Sphere-9 catheter can successfully treat...
atrial fibrillation ablation

EHRA 2023: Novel score predicts heart failure following atrial fibrillation ablation

A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation (AF) ablation, according...

EHRA 2023: AF patients have an average of five co-existing medical...

A novel software tool set to improve the management of elderly atrial fibrillation (AF) patients with multiple conditions is being designed by the EU-funded...
hypertrophic cardiomyopathy

EHRA 2023: Extended ECG monitoring detects more arrhythmias in hypertrophic cardiomyopathy

Thirty-day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking...
statins

EHRA 2023: Statin use associated with lower risk of stroke in...

A region-wide study in more than 50,000 patients with atrial fibrillation (AF) has found reduced risks of stroke and transient ischaemic attack in those...
atrial fibrillation

Health benefits of early rhythm control come with “reasonable” costs for...

Patients with atrial fibrillation (AF) have been said to benefit from early rhythm control therapy, which reduces cardiovascular deaths, strokes, and other adverse outcomes...
heartbeam

HeartBeam accquires LIVMOR assets

HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electrocardiogram (VECG) platform for heart attack detection today announced the strategic acquisition of...
AF

Acesion announces positive phase two data from AF clinical trial

Acesion, the biotech developing first-in-class novel therapies for atrial fibrillation (AF), has today announced positive data from its phase two trial of AP30663, a...
atrial fibrillation

Analysis of NIS database shows racial disparities in atrial fibrillation outcomes...

Using data from a large and “nationally representative” sample of the US population, a recent study is the first—the authors posit—to demonstrate racial differences...
early rhythm control

Early rhythm control aids recurrent stroke prevention in patients with AF

Early rhythm control one year after atrial fibrillation (AF) diagnosis has been found to be beneficial in preventing recurrent stroke in patients with incident...
AF

Inpatient AF ablation associated with early mortality and post-procedure complications, study...

Atrial fibrillation (AF) ablation carried out in an inpatient setting is associated with higher rates of early mortality and subsequent complications when compared with...

Brainomix technology integrated into new UK atrial fibrillation study

Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
atrial fibrillation

Basketballer Kareem Abdul-Jabbar joins campaign to raise awareness of atrial fibrillation

Kareem Abdul-Jabbar is working with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AF) and its symptoms as part of the...
heartbeat

Researchers map potential genetic regulators of the heartbeat

  University of Texas (UT) Southwestern Medical Center researchers have mapped gene control elements in specialised cardiac cells responsible for heartbeat regulation. The findings of...

Continuous monitoring detects atrial fibrillation in 20% of atherosclerotic stroke survivors

In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...

AF Symposium hears late-breaking data from RFA and PFA trials

Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
af

Periodontitis linked to increased risk of AF in Japanese study

Researchers have found a correlation between periodontitis and fibrosis scarring to an appendage of the heart’s left atrium that can lead to atrial fibrillation...
AF

Digital cardiovascular care company tenacio launches US OptiCor AF patient management...

tenacio, a company focused on digitising cardiovascular care to improve patient outcomes and reduce healthcare costs, has announced its OptiCor patient management platform is...

Atrial fibrillation does not modify treatment effect of bridging thrombolysis, study...

An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...

Systematic review and meta-analysis finds P-wave duration to increase risk of...

In their updated meta-analysis of 4,175 patients, Stergios Intzes together with a team from the Democritus University of Thrace, Alexandroupoli, Greece and the Heart...

Measurement of left atrial mechanical function found to improve stroke prediction

A cohort study of more than 4,500 persons without a history of atrial fibrillation (AF) or stroke has found that measuring left atrial mechanical...

“More research needed” before smartwatches are promoted for heart rhythm disorder...

More scientific evaluation is needed to develop and validate consensus recommendations to ensure that benefits will outweigh risks for consumers who use smartwatches in...

Shared decision-making tool reduces decision conflict and patient regret in use...

A recent presentation by Paul J Wang (Stanford School of Medicine, Stanford, USA) at the American Heart Association (AHA) Scientific Session 2022 conference (5-7...
atrial fibrillation

AF Symposium 2022: Lower pulmonary vein to left atrium volume ratio...

Pulmonary vein-left atrial (PV/LA) volume ratio is a significantly better predictor power for atrial fibrillation (AF) recurrence than LA dimension in patients with normal...

AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies...

Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
ablation

Same-day discharge for catheter ablation of atrial fibrillation deemed safe and...

A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...

Physcological stress linked with initiation and potentiation of AF

A review paper published in JACC: Clinical Electrophysiology explores the potential mechanisms linking stress and atrial fibrillation (AF), and the possible uses of stress...
ablation

Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment 

Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Jose Osorio

Q-FFICIENCY trial shows promise for temperature-controlled ablation  

Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
Atrian

AtriAN Medical present results of Neural AF trial at AF Symposium...

According to a press release, AtriAN Medicals clinical data from the Neural atrial fibrillation (AF) study was presented by Vivek Reddy (Mount Sinai Hospital,...

AF risk increases during the first year after breast cancer diagnosis in...

Women diagnosed with breast cancer are significantly more likely to develop atrial fibrillation (AF) compared to women without cancer, according to research published in...
AF

Patients with both atrial fibrillation and diabetes less likely to notice...

Adults with type 1 or type 2 diabetes and atrial fibrillation (AF) are less likely to notice irregular heartbeat symptoms, more likely to have...

LIVE from SNIS: Bridging therapy independently predicts haemorrhagic complications in atrial...

Exposure to bridging therapy independently predicts haemorrhagic complications—without improving functional outcomes—in patients with atrial fibrillation (AF) associated stroke. The findings from this retrospective, registry...

Study shows LAAO reduces major bleeding and mortality compared with NOACs...

Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score-matched study which examined left atrial appendage occlusion (LAAO) compared with novel...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

CardioFocus treats first patients with HeartLight endoscopic ablation system in France

CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...
atrial fibrillation

ESC 2019: Catheter ablation may be up to 10 times more...

Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...

More than 40% of patients with a history of atrial fibrillation...

Patients with a previous diagnosis of atrial fibrillation who were assessed as attending the emergency department inappropriately did so because of fear, or as...
Cardiac Rhythm news for specialists

New harmonised outcome measures for AF published

New harmonised outcome measures for atrial fibrillation (AF) have been published in HeartRhythm. The work was funded by the Agency for Healthcare Research and...
Cardiac Rhythm news for specialists

Migraines that affect vision may increase risk of irregular heartbeat

People who experience migraine with visual aura may have an increased risk of atrial fibrillation, according to a study published in the online issue...

Smartphone apps launched for atrial fibrillation patients and their healthcare providers

Two novel smartphone and tablet applications (apps) for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The two apps will...

Long working hours associated with higher risk of atrial fibrillation

By Angela Gonzalez People working 55 hours or more a week had an approximately 40% higher risk of atrial fibrillation compared with people working 35...

US FDA clears Cardiologs ECG Analysis platform

Cardiologs Technologies SAS has received US Food and Drug Administration (FDA) clearance of its ECG Analysis platform, a cloud-based cardiac monitoring-analysis web service powered...

Sensor-based CRT optimisation benefits sicker patients

This video has been sponsored by LivaNova. The RESPOND-CRT clinical trial is a relevant and significant study in the field of cardiac resynchronisation therapy. It...

Abbott receives CE mark for its Confirm Rx insertable cardiac monitor...

Abbott has announced CE mark and first use of the new Confirm Rx ICM. According to a company release, this is the world’s first smartphone...

Discover the latest evidence and ablation techniques for persistent AF treatment

Join atrial fibrillation (AF) experts Prof Richard Schilling (St Barts Hospital, London UK), Prof Carlo de Asmundis (Universitair Ziekenhuis, Brussels, Belgium) and PD Dr...

Moderate, habitual alcohol intake associated with atrial fibrillation

People who binge drink often experience an irregular heartbeat or a heart “flutter,” sometimes referred to as “holiday heart syndrome.” However, people who drink...